Mild cognitive impairment: long-term course of four clinical subtypes

A Busse1, A Hensel, U Gühne

  • 1Department of Psychiatry, University of Leipzig, Leipzig, Germany.

Neurology
|December 28, 2006
PubMed
Abstract

Insights

This study validates four subtypes of mild cognitive impairment (MCI). Modified criteria best predict dementia risk, though subtype-specific dementia progression is only partially confirmed.

Area of Science:

  • Neurology
  • Gerontology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) is a transitional state between normal cognition and dementia.
  • The expanded concept of MCI categorizes it into four clinical subtypes: amnestic MCI-single domain, amnestic MCI-multiple domains, nonamnestic MCI-single domain, and nonamnestic MCI-multiple domains.
  • Understanding the prevalence, course, and outcomes of these subtypes is crucial for early diagnosis and intervention.

Purpose of the Study:

  • To empirically validate the four clinical subtypes of mild cognitive impairment (MCI).
  • To examine the prevalence, course, and outcome of these four MCI subtypes in an elderly community sample.
  • To determine the relative predictive power of stable MCI for dementia onset.

Main Methods:

  • A community sample of 980 dementia-free individuals aged 75+ from the Leipzig Longitudinal Study of the Aged (LEILA 75+) was studied over 6 years.
  • Neuropsychological testing was used to diagnose four MCI subtypes based on original and modified Petersen et al. (2001) criteria (cutoffs of 1.0 SD and 1.5 SD).
  • Outcomes including dementia, death, improvement, and diagnostic stability were analyzed, and the predictive power of MCI for dementia onset was assessed.

Main Results:

  • MCI-single domain subtypes were more frequent than MCI-multiple domains; nonamnestic MCI was as frequent as amnestic MCI.
  • Modified MCI criteria with a 1.0 SD cutoff demonstrated the highest predictive power for dementia development (sensitivity 74%, specificity 73%).
  • Alzheimer's disease was the most common dementia type, but nonamnestic MCI-multiple domains predicted progression to non-AD dementia.

Conclusions:

  • The study partially supports the assumption that specific MCI subtypes are associated with an increased risk for particular types of dementia.
  • The findings highlight the importance of using validated criteria for MCI subtyping to improve dementia risk prediction.
  • Further research is needed to fully elucidate the relationship between MCI subtypes and dementia progression pathways.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...